GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (OTCPK:SHPGF) » Definitions » Inventory-to-Revenue

Shire (SHPGF) Inventory-to-Revenue : 0.88 (As of Sep. 2018)


View and export this data going back to . Start your Free Trial

What is Shire Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shire's Average Total Inventories for the quarter that ended in Sep. 2018 was $3,406 Mil. Shire's Revenue for the three months ended in Sep. 2018 was $3,872 Mil. Shire's Inventory-to-Revenue for the quarter that ended in Sep. 2018 was 0.88.

Shire's Inventory-to-Revenue for the quarter that ended in Sep. 2018 increased from Jun. 2018 (0.85) to Jun. 2018 (0.88)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Shire's Days Inventory for the three months ended in Sep. 2018 was 268.48.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shire's Inventory Turnover for the quarter that ended in Sep. 2018 was 0.34.


Shire Inventory-to-Revenue Historical Data

The historical data trend for Shire's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Inventory-to-Revenue Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.08 0.09 0.18 0.23

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.81 0.88 0.85 0.88

Competitive Comparison of Shire's Inventory-to-Revenue

For the Biotechnology subindustry, Shire's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shire's Inventory-to-Revenue falls into.



Shire Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shire's Inventory-to-Revenue for the fiscal year that ended in Dec. 2017 is calculated as

Inventory-to-Revenue (A: Dec. 2017 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2016 ) + Total Inventories (A: Dec. 2017 )) / count ) / Revenue (A: Dec. 2017 )
=( (3562.3 + 3291.5) / 2 ) / 15160.6
=3426.9 / 15160.6
=0.23

Shire's Inventory-to-Revenue for the quarter that ended in Sep. 2018 is calculated as

Inventory-to-Revenue (Q: Sep. 2018 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2018 ) + Total Inventories (Q: Sep. 2018 )) / count ) / Revenue (Q: Sep. 2018 )
=( (3353.3 + 3458.7) / 2 ) / 3871.7
=3406 / 3871.7
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shire  (OTCPK:SHPGF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shire's Days Inventory for the three months ended in Sep. 2018 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2018 )/Cost of Goods Sold (Q: Sep. 2018 )*Days in Period
=3406/1157.6*365 / 4
=268.48

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shire's Inventory Turnover for the quarter that ended in Sep. 2018 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2018 ) / Average Total Inventories (Q: Sep. 2018 )
=1157.6 / 3406
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shire Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shire's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPGF) Business Description

Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.

Shire (SHPGF) Headlines